Search Results:

Galeano on Di Stefano

The entire playing field fit inside his shoes. From his feet it sprouted and grew. Alfredo Di Stefano ran and re-ran the field from net to net. He would change flanks and rhythm with the ball, from a lazy trot to an unstoppable cyclone; without the ball he’d evade his marker to gain open space, seeking air whenever a play would get choked off.

He never stood still. Holding his head high, he…

MNC Pharma Companies & the Indian Market

“Is this going to have a big effect on our business model? No, because we did not develop this product for the Indian market, let’s be honest. We developed this product for Western patients who can afford this product, quite honestly. It is an expensive product, being an oncology product.” ~ Marijn Dekkers, Bayer Chief Executive Officer

The global pharma industry’s reputation is getting worse, and is only slightly better than health insurers. Statements,…

Indian Pharma – A case of regulatory failure?

Disclaimer: I work for Novartis, an MNC pharmaceutical player. However, the view expressed in the post are my own, and do not reflect those of my employer.

Indian pharmaceutical companies cannot be judged by American standards. – GN Singh, Drug Controller General of India

If you are looking for one reason for the mess that the Indian pharma industry is in, you do not…

Dilli ki sardi & Biking

A random discussion on Delhi winters with some colleagues reminded of the joys of riding on a winter evening in Delhi. The cold, slightly damp, wind across your face. The fog. The warmth of the engine. And the fog that doesn’t let you see too far in the distance, and because you are riding slowly you are actually enjoying the view. Missing my bike and those rides with Tk so much!

These lines by Robert Pirsig in